CT-MRI in Diagnosis and Staging in Lung Cancer

  • John A. PapailiouEmail author


Lung cancer stage classification system is correlated with the anatomical extent of the disease based on the characteristics of the primary tumor (T), the invasion of the regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) has been working closely with all of its member organizations throughout the development of the recently published 8th Edition of the TNM classification for lung cancer. The main changes are the following: T component is subdivided by primary tumor size in 1cm increments. The N component is determined by the location of infiltrated lymph nodes. The M component is subdivided into intrathoracic dissemination, a single extrathoracic metastasis and many metastases.

The implementation of the 8th Edition was delayed to January 1, 2018. Since there is not yet validated by large clinical series, this chapter is still based on the previous 7th Edition. Concerning imaging what seems more important is the accurate tumor size measurement and the correct evaluation of the number of metastatic sites.

CT and MRI imaging are considered as useful for precise assessment of tumor extent. Additionally, CT is helpful in guiding invasive biopsy procedures. MRI is the noninvasive procedure of choice in the evaluation of superior sulcus tumors and those lesions with suspected vascular, pericardial, or cardiac invasion. MRI is also complementary to CT in the evaluation of chest wall invasion and distant metastases.


NSCLC Diagnosis Staging CT MRI 


  1. 1.
    Henschke CI, McCauley DI, Yankelevitz DF et al (1999) Early lung cancer action project: overall design and findings from baseline screening. Lancet 354:99–105CrossRefGoogle Scholar
  2. 2.
    US Preventive Services Task Force (2004) Lung cancer screening: recommendation statement. Ann Intern Med 140:738–739CrossRefGoogle Scholar
  3. 3.
    Swensen SJ, Viggiano RW, Midthun DE et al (2000) Lung nodule enhancement at CT: multicenter study. Radiology 214:73–80CrossRefGoogle Scholar
  4. 4.
    Hassan I, Gross BH (2011) MD imaging in lung cancer staging. Med scape reference. Drugs diseases and procedures. Multimedia library. May 27Google Scholar
  5. 5.
    Glazer HS, Duncan-Meyer J, Aronberg DJ et al (1985) Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 157:191–194CrossRefGoogle Scholar
  6. 6.
    Herman SJ, Winton TL, Weisbrod GL et al (1994) Mediastinal invasion by bronchogenic carcinoma: CT signs. Radiology 190:841–846CrossRefGoogle Scholar
  7. 7.
    White PG, Adams H, Crane MD et al (1994) Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours? Thorax 49:951–957CrossRefGoogle Scholar
  8. 8.
    Toloza EM, Harpole L, Detterbeck F et al (2003) Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123:157S–166SCrossRefGoogle Scholar
  9. 9.
    Musset D, Grenier P, Carette MF et al (1986) Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 160:607–611CrossRefGoogle Scholar
  10. 10.
    Laurent F, Montaudona M, Corneloupb O (2006) CT and MRI of lung cancer. Respiration 73:133–142CrossRefGoogle Scholar
  11. 11.
    Coughlin M, Deslauriers J, Beaulieu M et al (1985) Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorax Surg 40:556–560CrossRefGoogle Scholar
  12. 12.
    Boland GW, Lee MJ, Gazelle GS et al (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201–204CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.CT DepartmentKostantopoulio General HospitalAthensGreece

Personalised recommendations